On-demand webinar
Impact of Process
Re-design on Sustainability
in Pharmaceutical Small Molecule Manufacturing:
A Case Study
A recent study revealed, that the pharmaceutical industry is significantly more emission-intensive than the automotive industry1. In a cradle-to-grave perspective, the impact of supply chain on the carbon footprint of pharmaceutical companies operations by far exceeds the impacts related to waste production and treatment2, 3.
Therefore, it is of highest priority that pharmaceutical manufacturing becomes more efficient regarding the use of resources.
In this webinar, we:
- Extensively describe the optimization of the manufacturing process of a pharmaceutical intermediate
- Demonstrate that yield can be improved substantially via suitable reaction engineering
- Show that the implemented optimizations come along with a net increase in quality of the obtained intermediate
Simply complete the form to register.
Meet our Speakers
Antoine Klaue
Laboratory Head MSAT, Process Technology
Lonza Small Molecules
Dr. Antoine Klaue has a Bachelor's and Master’s degree in Chemical Engineering from ETH Zurich, where he proceeded with his PhD in the Group of Massimo Morbidelli. Since 2019, he has been working as a MSAT Chemist at Lonza Visp where he focused on process development, scale-up and optimization in pharmaceutical small molecules manufacturing.
Angela Diaz Velasco
Associate Director, Sales
Lonza Small Molecules
Angela Diaz Velasco has over 10 years of (Account Management) experience in the pharmaceutical industry and has worked with customers across different industries and regions for more than 15 years. She joined Lonza in March 2022 as an Associate Director, Account Management. She received her degree in Chemical Engineering at the Minas Faculty of the National University of Colombia.
- L. Belkhir, A. Elmeligi, Journal of Cleaner Production, 2019, 214, 185-194.
- C. Jimenez-Gonzalez, C. S. Ponder, Q. B. Broxterman, J. B. Manley, Org. Process Res. Dev. 2011, 15, 4, 912–917.
- Lonza Sustainability Report 2021, 2022, 35 ff.
